ENDOMETRIAL HYPERPLASIA WITH CELLULAR ATYPIA

This adverse event was reported 28 times

These drugs are most commonly taken by patients reporting ENDOMETRIAL HYPERPLASIA WITH CELLULAR ATYPIA:

# Drug Count
0 ESTRADIOL 5
1 ESTRADIOL GEL 0.1% 5
2 ESTRADIOL TRANSDERMAL 5
3 ESTRADIOL, 5
4 LEVONORGESTREL 5
5 APIXABAN 3
6 RISANKIZUMAB-RZAA 3
7 CONJUGATED ESTROGENS 2
8 ERGOCALCIFEROL 2
9 ESTROGENS, CONJUGATED 2
See all common drugs associated with ENDOMETRIAL HYPERPLASIA WITH CELLULAR ATYPIA

ENDOMETRIAL HYPERPLASIA WITH CELLULAR ATYPIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SETMELANOTIDE 1 0.0035
1 TOREMIFENE CITRATE 1 0.0023
2 SATRALIZUMAB 1 0.0006
3 TESTOSTERONE UNDECANOATE 1 0.0005
4 UBROGEPANT 1 0.0002
5 TRANEXAMIC ACID 1 0.0001
6 CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES 1 0.0001
7 ESTRADIOL TRANSDERMAL 5 0.0001
8 SELEXIPAG 2 0.0001
9 HEPARIN SODIUM 1 0.0001
See all drugs enriched for association with ENDOMETRIAL HYPERPLASIA WITH CELLULAR ATYPIA